Abstract
Molecular analysis of a protein highly expressed in human breast cancer, indicates the presence of a polymorphic tandem repeat domain that encodes a conserved 20 amino acid repeat motif rich in serine and threonine residues that in the mature protein, designated MUC1, are linked via O-glycosidic linkages to sugar residues. Recent studies performed in our laboratory have led to the molecular characterization of a novel MUC1 repeat array minus mRNA, generated by an alternative splicing event that deletes the central tandem repeat array and its flanking sequences. The conceptually derived amino acid sequence of the novel MUC1 protein shows that it is identical with the previously reported transmembrane MUC1 amino acid sequence except for the deletion of the central 20 amino acid tandem repeat array and sequences immediately flanking the repeat array. This indicates that the novel MUC1 protein, which is devoid of the “hallmark” feature of mucins, the tandem repeat array, may be functionally different to the much larger, heavily glycosylated polymorphic repeat array containing MUC1 proteins, that affect cell-cell interactions. Based on an analysis of its peptide sequence, we propose the hypothesis that the novel MUC1 protein may act as a receptor molecule that modulates signal transduction. Preliminary experimental data supports this hypothesis. It appears, therefore, that the MUC1 gene is multifunctional with regard to its protein products- the repeat array containing MUC1 proteins may alter cellular adhesion processes whereas the novel MUC1 protein could be acting as a receptor-like molecule participating in signal transmission.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ceriani, R.L., Peterson, J.A. and Blank, E.W. (1984). Cancer Res. 44, 3033–3039.
Keydar, I., Chou, C.S., Hareuveni, M., Tsarfaty, I., Sahar, E., Seltzer, G., Chaitchik, S. and Hizi, A. (1989) Proc. Natl. Acad. Sci. USA, 86, 1362–1367.
Abe, M. and Kufe, D. J. Cell Physiol. (1986) 126, 126–136.
Bramwell, M.E., Bhavanandan, V.P., Wiseman, G. and Harris, H. (1983) Br. J. Cancer 48, 177–183.
Burchell, J., Gendler, S., Taylor-Papadimitriou, J., Girling, A., Lewis, A., Millis, R. and Lamport, D. (1987) Cancer Res. 47, 5476–5482.
Hilkens, J., Buijs, F., Hilgers, J., Hageman, P., Calafat, J., Sonnenberg, A. and van dar Valk, M. (1984) Cancer 34, 197–204.
Johnson, V.G., Schlom, J., Paterson, A.J., Bennett, J., Magnani, J.L. and Colcher, D. (1986) Cancer Res. 46, 850–857.
Lan, M.S., Finn, O.J., Fernsten, P.D. and Metzgar, R.S. (1985) Cancer Res. 45, 305–310.
Tjandra, J J. and McKenzie, I.F.C. (1988) Br. J.Surg. 75, 1067–1075.
Wreschner, D.H., Tsarfaty, I., Hareuveni, M., Zaretsky, J., Smorodinsky, N., Weiss, M., Horev, J., Kotkes, P., Zrihan, S., Jeltsch, J-M., Green, S., Lathe, R., and Keydar, I. (1989) In: Breast Cancer: Progress in biology, clinical management and prevention, pp 41–59, Eds. Rich, M.A., Hager, J.C. and Keydar, I., Boston: Kluwer Academic Publishers.
Wreschner, D.H., Hareuveni, M., Tsarfaty, I, Smorodinsky, N., Horev, J., Zaretsky, J., Kotkes, P., Weiss, M., Lathe, R., Dion, A.S., and Keydar, I. (1990). Eur. J. Biochem. 189: 463–473.
Abe, M., Siddiqui, J. and Kufe, D. (1989) Biochem. Biophys. Res. Commun. 165, 644–649.
Gendler, S.J., Lancaster, C.A., Taylor-Papadimitriou, J., Duhig, T., Peat, N., Burcheli, J., Pemberton, L., Lalani, E-N. and Wilson, D. (1990) J. Biol. Chem. 265, 15286–15293.
Ligtenberg, M.J.L., Vos, H.L., Genissen, A.M.C. and Hilkens, J. (1990) J. Biol. Chem. 265, 15573–15578.
Lan, M.S., Batra, S.K., Qi, W-N, Metzgar, R.S. and Hollingworth, M.A. (1990) J. Biol. Chem. 265, 15294–15299.
Ligtenberg, M.J.L., Buijs, F., Vos, H.L., and Hilkens, J. (1992) Cancer Res. 52, 2318–2324.
Hartman, M., Tsarfaty, L, Hareuveni, M., Keydar, J. and Wreschner, D.H. (1992). In: “Senology” L. Ioannidou-Mouzaka, N.J. Agnantis and I. Karydas (Eds.) Elsevier Science Publishers, pp 379–383.
Spicer, A.P., Parry, G., Patton, S. and Gendler, S.J. (1991) J.Biol. Chem. 266, 15099–15109.
Shurtleff, S.A., Downing, J.R., Rock, CO., Hawkins, S.A., Roussel, M.F. and Sherr, C.J. (1990) EMBO J. 9, 4215–4221.
Reedijk, M., Liu, Y. and Pawson, T. (1990). Mol. Cell Biol. 10, 5601–5608.
Anderson, D., Koch, C.A., Grey, L., Ellis, C, Moran, M.F. and Pawson, T. (1990) Science 250, 979–982.
Moran, M., Koch, C.A., Anderson, D., Ellis, C, England, C, Martin, G.S. and Pawson, T. (1990) Proc. Natl. Acad. Sci. USA 87, 8622–8626.
Escobedo, J.A., Kaplan, D.R., Kavanaugh, W.M., Turck, C.W. and Williams, L.T. (1991) Mol. Cell. Biol. 11, 1125–1132.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wreschner, D.H. et al. (1994). Does a Novel form of the Breast Cancer Marker Protein, MUC1, Act as a Receptor Molecule that Modulates Signal Transduction?. In: Ceriani, R.L. (eds) Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment. Advances in Experimental Medicine and Biology, vol 353. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2443-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2443-4_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6038-4
Online ISBN: 978-1-4615-2443-4
eBook Packages: Springer Book Archive